Biogen has been granted a patent for compounds of Formula (I) and their pharmaceutically acceptable salts, along with methods for their use and production. The patent claim specifies a compound selected from this formula. GlobalData’s report on Biogen gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Biogen Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Biogen, Personalized cancer vaccines was a key innovation area identified from patents. Biogen's grant share as of January 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.

Compounds of formula (i) for pharmaceutical use

Source: United States Patent and Trademark Office (USPTO). Credit: Biogen Inc

A recently granted patent (Publication Number: US11858926B2) discloses a series of claims related to a compound selection. Claim 1 outlines the selection of a compound, while subsequent claims 2, 3, 4, and 5 provide further specifications on the nature of the compound chosen. These claims indicate a focus on a specific compound or group of compounds within the patent's scope.

The claims within the patent suggest a detailed exploration of a particular compound or compounds, potentially indicating a novel discovery or application within the field. The specificity of the claims highlights the importance of the selected compound(s) within the patent's overall innovation. This patent could have implications for various industries, including pharmaceuticals, materials science, or other fields where the identified compound(s) may have significant value or utility. Further analysis and research into the compound(s) outlined in the claims could provide valuable insights and potential advancements in relevant areas of study.

To know more about GlobalData’s detailed insights on Biogen, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies